Matritech Inc.

Ms. Randall has been Matritech's Vice President, General Counsel, Chief Legal Officer and Secretary since December 2003. From 2001 to 2003, Ms. Randall served as Vice President and General Counsel of Robotic Vision Systems, Inc., a publicly traded technology company. From 1998 to 2000, she served as Vice President and General Counsel of Hadco Corporation, a publicly traded technology company. From 1980 to 1998, Ms. Randall was a partner at the Boston law firm of Hamilton, Dahmen and Randall.

Mr. Kolasinski, a veteran diagnostic and point-of-care product sales executive with more than 30 years of experience joined the Company as Vice President, Sales in March 2006. Mr. Kolasinski built and led the point-of-care sales team at Boehringer Mannheim, one of the world's largest in vitro diagnostic (IVD) companies and now Roche Boehringer Mannheim Diagnostics. At Boehringer Mannheim he successfully marketed new IVD products directly to physicians, increasing both sales and market share. Before joining Matritech, Mr. Kolasinski was Vice President of Business Development of Inproteo, the Indiana Proteomics Consortium, which is owned by Eli Lilly, Indiana University and Purdue University. Previously he held a number of senior positions in sales and commercial operations in large diagnostic companies including Amersham Corporation/Life Sciences Division as Vice President and General Manager; Abbott Laboratories/Diagnostic Division, where he held a number of positions of increasing responsibility in worldwide sales and marketing; and at Baxter Laboratories, where he held several positions in sales and marketing management for its diagnostic products.

Dr. Fagan has been Matritech's Vice President, Research and Development, since October 2004, and joined the Company in November 2003 as Senior Director of Product Development. Prior to joining Matritech, Dr. Fagan served from 1999 to November 2003 as Vice President, Research and Development, of Ischemia Technologies, an in-vitro diagnostics company. From 1989 to 1998, he served in a number of research positions at PB Diagnostics and Behring Diagnostics, both predecessor companies to Dade Behring, before serving as a senior research manager at Dade Behring, a publicly-traded diagnostics company.

Mr. Quigley has been Matritech's Vice President, Sales and Marketing since July 2001. From December 2000 until April 2001, he was Director of Marketing for Argose, Inc., a medical diagnostic products company. From 1998 until May 2000, Mr. Quigley was the Vice President of Global Marketing for Bayer's Critical Care business unit. From January 1997 until 1998, Mr. Quigley was Director of U.S. Marketing at Chiron Diagnostics, a publicly traded biotech and diagnostics company that was acquired by Bayer. From 1994 until 1997, Mr. Quigley was Director of Marketing at Boehinger Mannheim, a privately held diagnostics company.

Dr. Rosenthal was elected as a director of Matritech on January 22, 2007. Dr. Rosenthal has been president, chief executive officer and a member of the board of directors of Magellan Biosciences, Inc., a private biotechnology company engaged in the development and marketing of rapid point-of-care analyzers and automated systems for hospital-based labs and near-patient testing, since 2005. From 2003 to 2006, he served as president, chief executive officer and a member of the board of directors of TekCel, Inc., a private manufacturer of automated sample-management systems for life science research. Dr. Rosenthal was president and CEO of Boston Life Sciences, an R&D development-stage biopharmaceutical company from 2002 to 2003. From 2001 to 2002, Dr. Rosenthal was president and chief executive officer of Magellan Discovery Technologies, LLC, a private company focused on development of drug discovery tools. In addition to the Magellan and subsidiary boards, Dr. Rosenthal serves as a director for several other companies, including the board of Cambrius, a private sensor-technology company focused on process solutions and the University of Maryland Department of Chemistry and Biochemistry Board of Advisors. He is also a member of the University of Maryland, College of Chemical and Life Sciences Board of Visitors.

Mr. Fredericks has served as a director of Matritech since July 2003. Mr. Fredericks is currently a member of, and is responsible for the financial affairs of, Adirondack Boat, LLC, a distributor of electronic boats. From 1999 to 2001, Mr. Fredericks served as president, chief executive officer and director of Lifecodes Corporation, a forensics DNA testing company. Mr. Fredericks was the founder of, and from 1993 to 2001, served as chief executive officer and director of Electronic Instruments International, a company focused on creating products to enhance long distance electric power distribution. From 1989 to 1997, he also served as a director of DIANON Systems, Inc., a publicly traded oncology marketing and database company.